Cargando…

EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine

Detalles Bibliográficos
Autores principales:	Schankin, C, Maniyar, F, Seo, Y, Kori, S, Eller, M, Blecha, J, Murphy, S, Sprenger, T, VanBrocklin, H, Goadsby, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182228/ http://dx.doi.org/10.1186/1129-2377-15-S1-F22

Ejemplares similares

Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for (11) C-dihydroergotamine during glyceryl trinitrate-induced migraine
por: Schankin, Christoph J., et al.
Publicado: (2016)

Imaging the premonitory phase of migraine - new insights into generation of the migraine attack
por: Maniyar, FH, et al.
Publicado: (2013)

EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0186. Multi-center 3T MRI study of cortical thickness abnormalities in migraine
por: Magon, S, et al.
Publicado: (2014)

The origin of nausea in migraine–A PET study
por: Maniyar, Farooq H, et al.
Publicado: (2014)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0036. Gammacore device for treatment of migraine attack: preliminary report
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0193. The impact of cognitive symptoms on migraine attack related disability
por: Gil-Gouveia, R, et al.
Publicado: (2014)

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
por: Kori, S, et al.
Publicado: (2013)

EHMTI-0174. Dural vessel hemodynamics during normal behavior and migraine attack
por: Gao, Y, et al.
Publicado: (2014)

EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal
por: Woldeamanuel, YW, et al.
Publicado: (2014)

EHMTI-0024. The typical duration of migraine aura: a prospective diary-based study
por: Viana, M, et al.
Publicado: (2014)

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

EHMTI-0372. No abnormalities of intrinsic brain connectivity during the interictal phase of migraine with aura
por: Hougaard, A, et al.
Publicado: (2014)

EHMTI-0104. VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0181. Fast recovery of visual evoked potential amplitude after photostress in migraine patients between attacks
por: Coppola, G, et al.
Publicado: (2014)

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase
por: Song, G, et al.
Publicado: (2014)

EHMTI-0079. Reduced volume of anterior thalamic nuclei in migraineurs
por: Magon, S, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0049. Headache, migraine and epileptic seizures
por: Gligic, N, et al.
Publicado: (2014)

EHMTI-0089. Relationship of sleep bruxism and migraine
por: Kato, M, et al.
Publicado: (2014)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine
por: Bhola, R, et al.
Publicado: (2014)

Structural and functional footprint of visual snow syndrome
por: Schankin, Christoph J, et al.
Publicado: (2020)

EHMTI-0122. Serum micrornas as potential biomarkers of migraine
por: Andersen, HH, et al.
Publicado: (2014)

EHMTI-0107. Treatment of migraine in Croatia, year 2013
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0358. Improved chronic migraine after DTMS
por: Scatena, P, et al.
Publicado: (2014)

EHMTI-0348. Refractive errors in patients with migraine headache
por: Gunes, A, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0070. Effect of occlusal sprint in migraine patients
por: Takeuchi, M, et al.
Publicado: (2014)

EHMTI-0374. Gene-based pleiotropy across migraine with and migraine without aura
por: Nyholt, D, et al.
Publicado: (2014)

EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014)

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
por: Goadsby, P, et al.
Publicado: (2014)

EHMTI-0237. The A11 hypothalamic nucleus is susceptible to nitric oxide signalling
por: Andreou, AP, et al.
Publicado: (2014)

EHMTI-0187. A novel ATP1A2 mutation in a case of familial hemiplegic migraine with especially severe attacks
por: Martínez, E, et al.
Publicado: (2014)

EHMTI-0249. Headache attributed to hypertension in chronic migraine patients
por: Grosu, O, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uv13sarrvgjpi9c3sheo5c39rs